Argenx Advances Clinical Development of ARGX-119 i...
Category : Clinical Trial Update 30 June 2025Overview argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improv...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Bavarian Nordic initiates clinical trials of mpox...
Category : Clinical Trial Update 30 June 2025Overview Bavarian Nordic A/S, a global vaccine company with a mission to improve health and save...
GEMZ Phase 3 study of fenfluramine shows positive...
Category : Clinical Trial Update 30 June 2025Overview UCB, a global biopharmaceutical company, today announced that the Phase 3 study investig...
Nicox Announces Last Patient Completes the NCX 470...
Category : Clinical Trial Update 30 June 2025Overview Nicox SA (Euronext Growth Paris: FR0013018124, ALCOX), an international ophthalmology co...
Edgewise Therapeutics announces positive results o...
Category : Clinical Trial Update 28 June 2025Overview Edgewise Therapeutics, Inc., a leading muscle disease biopharmaceutical company, unveile...
Latest Newsletter Post
-
Nicox Announces Last Patient Comple..
30 June 2025
-
GEMZ Phase 3 study of fenfluramine..
30 June 2025
-
Bavarian Nordic initiates clinical..
30 June 2025
-
Argenx Advances Clinical Developmen..
30 June 2025
-
Galderma starts Phase 2 trials of n..
28 June 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com